Displaying One Session

PER Global, LLC - Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors (ID 150)

Time
10:30 - 12:00

Welcome and Introductions (ID 4813)

Unmet Educational and Clinical Needs in Biomarker Testing: Key Concepts for the Multidisciplinary Team (ID 4814)

Novel HER2/3 and TROP2 Approaches in Breast Cancer: Integrating Recent Evidence (ID 4815)

A New Wave of Developments on HER2 Targeted Strategies in Gastric Cancer and Beyond: Implications for Testing and Treatment (ID 4817)

Exploring Unmet Needs in Advanced NSCLC: Rationale for Emerging Approaches Targeting HER2, HER3, TROP2, and Beyond! (ID 4819)

Q&A Session (ID 4820)

Closing Remarks & Meeting Adjourns (ID 5565)